Natrecor may increase chances of death, says research

Email this article to a friend

Printable Version

Doctors writing in the Journal of the American Medical Association (JAMA) have suggested that the heart drug Natrecor was associated with increased incidence of death in clinical trials. Representatives of Scios, the manufacturer of Natrecor, have denied that the drug is dangerous.

The JAMA study found that patients who took Natrecor were 80 percent more likely to die within a month than patients who took older and more affordable drugs instead. The FDA is not yet certain that Natrecor represents a danger, although FDA representatives say they are watching the debate closely. Scios has asked Harvard Medical School's Dr. Eugene Braunwald to organize a panel of independent heart experts to review the existing data.

Share

About the author: Mike Adams is a natural health researcher and author with a mission to teach personal and planetary health to the public He has authored and published thousands of articles, interviews, consumers guides, and books on topics like health and the environment, impacting the lives of millions of readers around the world who are experiencing phenomenal health benefits from reading his articles. Adams is an independent journalist with strong ethics who does not get paid to write articles about any product or company. In 2007, Adams launched EcoLEDs, a maker of super bright LED light bulbs that are 1000% more energy efficient than incandescent lights. He's also a successful software entrepreneur, having founded a well known email marketing software company whose technology currently powers the NaturalNews email newsletters. Adams is currently the executive director of the Consumer Wellness Center, a 501(c)3 non-profit, and regularly pursues cycling, nature photography, Capoeira and Pilates. Known on the 'net as 'the Health Ranger,' Adams shares his ethics, mission statements and personal health statistics at www.HealthRanger.org


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • JAMA caught red handed failing to disclose conflicts of interest, just one week after new "crackdown" announced • Scientific medical journals like JAMA fail basic credibility standards; medical journals become increasingly irrelevant • Did JAMA Editors Threaten a Big Pharma Whistleblower?	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/007656_JAMA_drugs_Journal_of_the_American_Medical_Association.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/007656_JAMA_drugs_Journal_of_the_American_Medical_Association.html">Natrecor may increase chances of death, says research</a>